| On the use of the Weibull function for the discernment of drug release mechanisms V Papadopoulou, K Kosmidis, M Vlachou, P Macheras International journal of pharmaceutics 309 (1-2), 44-50, 2006 | 793 | 2006 |
| Evaluation of high molecular weight poly (oxyethylene)(Polyox) polymer: studies of flow properties and release rates of furosemide and captopril from controlled-release hard … M Efentakis, M Vlachou Pharmaceutical Development and Technology 5 (3), 339-346, 2000 | 153 | 2000 |
| Development and evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems M Efentakis, A Koutlis, M Vlachou AAPS PharmSciTech 1, 62-70, 2000 | 122 | 2000 |
| Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release M Efentakis, S Koligliati, M Vlachou International journal of Pharmaceutics 311 (1-2), 147-156, 2006 | 108 | 2006 |
| Effects of excipients on swelling and drug release from compressed matrices M Efentakis, M Vlachou, NH Choulis Drug development and industrial pharmacy 23 (1), 107-112, 1997 | 74 | 1997 |
| Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility M Efentakis, I Pagoni, M Vlachou, K Avgoustakis International journal of pharmaceutics 339 (1-2), 66-75, 2007 | 51 | 2007 |
| Polymers for use in controlled release systems: the effect of surfactants on their swelling properties M Vlachou, N Hani, M Efentakis, PA Tarantili, AG Andreopoulos Journal of biomaterials applications 15 (1), 65-77, 2000 | 48 | 2000 |
| Fabrication and characterization of electrospun nanofibers for the modified release of the chronobiotic hormone melatonin M Vlachou, S Kikionis, A Siamidi, K Tragou, S Kapoti, E Ioannou, ... Current Drug Delivery 16 (1), 79-85, 2019 | 46 | 2019 |
| 3D-Printed oral dosage forms: Mechanical properties, computational approaches and applications D Karalia, A Siamidi, V Karalis, M Vlachou Pharmaceutics 13 (9), 1401, 2021 | 43 | 2021 |
| Pineal hormone melatonin as an adjuvant treatment for COVID‑19 M Vlachou, A Siamidi, A Dedeloudi, SK Konstantinidou, IP Papanastasiou International Journal of Molecular Medicine 47 (4), 1-1, 2021 | 41 | 2021 |
| Development and Characterization of Eudragit®-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of … M Vlachou, S Kikionis, A Siamidi, S Kyriakou, A Tsotinis, E Ioannou, ... Pharmaceutics 11 (9), 480, 2019 | 37 | 2019 |
| Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-β-cyclodextrin M Vlachou, G Papaïoannou Journal of biomaterials applications 17 (3), 197-206, 2003 | 36 | 2003 |
| Swelling properties of various polymers used in controlled release systems M Vlachou, H Naseef, M Efentakis, PA Tarantili, AG Andreopoulos Journal of biomaterials applications 15 (4), 293-306, 2001 | 35 | 2001 |
| Electrospinning and drug delivery M Vlachou, A Siamidi, S Kyriakou Electrospinning and electrospraying-techniques and applications, 1-22, 2019 | 33 | 2019 |
| Modified in vitro release of the chronobiotic hormone melatonin from matrix tablets based on the marine sulfated polysaccharide ulvan M Vlachou, K Tragou, A Siamidi, S Kikionis, AL Chatzianagnostou, ... Journal of Drug Delivery Science and Technology 44, 41-48, 2018 | 32 | 2018 |
| Environmental impacts due to the use of sunscreen products: a mini-review M Chatzigianni, P Pavlou, A Siamidi, M Vlachou, A Varvaresou, ... Ecotoxicology 31 (9), 1331-1345, 2022 | 31 | 2022 |
| Modified in vitro release of melatonin loaded in nanofibrous electrospun mats incorporated into monolayered and three-layered tablets M Vlachou, S Kikionis, A Siamidi, K Tragou, E Ioannou, V Roussis, ... Journal of Pharmaceutical Sciences 108 (2), 970-976, 2019 | 31 | 2019 |
| Development and in vitro evaluation of griseofulvin gels using Franz diffusion cells MD Vlachou, DM Rekkas, PP Dallas, NH Choulis International journal of pharmaceutics 82 (1-2), 47-52, 1992 | 31 | 1992 |
| Two-and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs M Efentakis, H Naseef, M Vlachou Drug Development and Industrial Pharmacy 36 (8), 903-916, 2010 | 30 | 2010 |
| Itraconazole in the treatment of tinea corporis and tinea cruris A Katsambas, CH Antoniou, E Frangouli, D Rigopoulos, M Vlachou, ... Clinical and experimental dermatology 18 (4), 322-325, 1993 | 27 | 1993 |
